Literature DB >> 34036300

Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes.

Rami Komrokji1, Virginia Volpe1, Onyee Chan1, Najla Al Ali1, David Swoboda1, Andrew Kuykendall1, Eric Padron1, David A Sallman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34036300     DOI： 10.1182/blood.2021010831

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  1 in total

1.  A Novel Prognostic Scoring Model for Myelodysplastic Syndrome Patients With SF3B1 Mutation.

Authors:  Liya Ma; Bin Liang; Huixian Hu; Wenli Yang; Shengyun Lin; Lihong Cao; Kongfei Li; Yuemin Kuang; Lihong Shou; Weimei Jin; Jianping Lan; Xingnong Ye; Jing Le; Huyi Lei; Jiaping Fu; Ying Lin; Wenhua Jiang; Zhiying Zheng; Songfu Jiang; Lijuan Fu; Chuanyong Su; XiuFeng Yin; Lixia Liu; Jiayue Qin; Jie Jin; Shenxian Qian; Guifang Ouyang; Hongyan Tong
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.